(Q45992860)
Statements
1 reference
Markov model and cost-effectiveness analysis of bevacizumab in HER2-negative metastatic breast cancer. (English)
1 reference
Tamer Refaat
1 reference
Mehee Choi
1 reference
Germaine Gaber
1 reference
Krystyna Kiel
1 reference
Minesh Mehta
1 reference
William Gradishar
1 reference
William Small
1 reference
1 October 2014
1 reference
37
1 reference
5
1 reference
480-485
1 reference